Columbia University Gout Management Recent Advances 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Rheumatologists, Nephrologists, Internists, Primary Care Physicians, Cardiologists, Endocrinologists, Medical Nutrition Specialists (Physician Nutrition Specialists), and Radiologists (Musculoskeletal Radiologists)

+ Sample video: contact me for sample video

+ Information:

• Course Title: Gout Management: Recent Advances 2026 (Recent Advances in Gout Management 2026)

• Organizer: Columbia Medicine (Columbia University) and Amedco LLC

• Date & Time: Friday, October 16, 2026 | 8:55 am to 2:00 pm EST

• Format: Virtual Conference / Online

• Course Directors: Jason Liebowitz, MD; Adam Mor, MD, PhD; Christine Parsons, MD; Jai Radhakrishnan, MD, MS

• Description: Planned and implemented by Amedco LLC and Columbia University, this virtual continuing education conference provides the healthcare team with the latest clinical updates in the diagnosis and management of gout. The curriculum covers global epidemiologic trends, advanced diagnostic imaging (DECT and ultrasound), nutritional factors, cardio-metabolic comorbidities, management in advanced chronic kidney disease (CKD), contemporary urate-lowering strategies beyond the ACR guidelines, novel therapeutic agents, and interactive case-based discussions.

Learning Objectives

After Attending This Program You Should Be Able To:

1. Describe current and emerging epidemiologic trends in gout, including factors contributing to increasing disease complexity and comorbidity burden.

2. Evaluate contemporary urate-lowering strategies, including treatment targets, optimal timing of therapy & common gaps between guidelines.

3. Explain the mechanisms of action, indications & safety considerations of biologic therapies used in refractory gout, and appropriate monitoring strategies.

4. Apply expert-recommended approaches to complex gout cases, integrating clinical experience with evidence-based guidelines.

5. Assess the role of co-therapy and immunomodulation in difficult-to-treat gout, including strategies to optimize efficacy while minimizing adverse effects.

6. Integrate gout management principles into the care of patients with advanced chronic kidney disease, balancing therapeutic risks and benefits.

7. Analyze treatment-resistant gout cases using interactive, case-based discussion to develop practical, patient-centered management plans.

Target Audience

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University to provide continuing education for the healthcare team. Professions in scope for this activity include Physicians, Nurse Practitioners, and Physician Assistants.

Best for Rheumatologists, Nephrologists, Internists, Primary Care Physicians, Cardiologists, Endocrinologists, Medical Nutrition Specialists (Physician Nutrition Specialists), and Radiologists (Musculoskeletal Radiologists).

Topics

Friday, October 16, 2026 (8:55 am to 2:00 pm EST)

• 8:55 am | Welcome

  • Course Directors: Jason Liebowitz, MD; Adam Mor, MD, PhD; Christine Parsons, MD; Jai Radhakrishnan, MD, MS

• 9:00 am | Gout in 2026: A Global Perspective

  • Caroline Atlas, MD, Assistant Professor of Medicine, Columbia

• 9:30 am | DECT & Ultrasound Imaging in the Diagnosis of Gout

  • Christine Parsons, MD, Assistant Professor of Medicine, Rheumatology, Columbia

• 10:00 am | Diet in Gout: How Much Does It Matter?

  • David S. Seres, MD, PhD, Professor of Medicine, Institute of Human Nutrition, Columbia

• 10:30 am | Q&A

• 10:45 am | Gout & Cardio-Metabolic Disease

  • Naomi Schlesinger, MD, Professor of Medicine, Rheumatology, University of Utah

• 11:15 am | Gout Treatment in 2026: Beyond the ACR Guidelines

  • Michael Pillinger, MD, Professor of Medicine, Biochemistry & Molecular Pharmacology, NYU

• 11:45 am | Gout Management in Advanced CKD

  • Vesh Srivatana, MD, Assistant Professor of Medicine, Nephrology, Columbia

• 12:15 pm | Novel Agents in the Treatment of Gout

  • Gregory Challener, MD, Assistant Professor of Medicine, Rheumatology, Columbia

• 12:45 pm | Interactive Case-Based Panel Discussion

  • Moderators: Adam Mor, MD, PhD; Christine Parsons, MD

  • Panelists: Naomi Schlesinger, MD; Michael Pillinger, MD; Vesh Srivatana, MD

• 1:15 pm | Q&A

• 1:30 pm | Non-CME Industry Theatre: KRYSTEXXA: Changing the Course of Uncontrolled Gout

  • Jeff R. Peterson, MD, FACR, Clinical Professor of Medicine, Rheumatology, U. of Washington

• 2:00 pm | Adjourn